NRGN and Alzheimer disease: The absence of associations in our sample, which included a range of AD stages, could also suggest that any influence of sαKl on non-specific markers like NfL, GFAP, and Ng is more detectable in preclinical or earlier stages of AD pathology, aligning with Driscoll et al.'s findings in cognitively unimpaired adults.